You are viewing an incomplete version of our website. Please click to reload the website as full version.

PIM1 antibody (Pim-1 Oncogene) (Internal Region)

Details for Product anti-PIM1 Antibody No. ABIN350744, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms cb1068, fj47b05, pim2, wu:fj47b05, PIM1, pim, pim-1, pim3, LON, LONP, LonHS, PRSS15, hLON, PIM, Pim-1
Internal Region
(40), (22), (15), (13), (13), (10), (10), (9), (9), (9), (7), (6), (6), (5), (5), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1)
Human, Mouse (Murine)
(164), (48), (48), (2), (2), (1), (1), (1)
(133), (46), (5)
This PIM1 antibody is un-conjugated
(11), (8), (5), (4), (4), (4), (3), (1), (1), (1), (1), (1), (1), (1), (1)
Immunohistochemistry (IHC), Western Blotting (WB)
(116), (103), (52), (41), (24), (13), (7), (7), (6), (6), (1), (1)
Pubmed 2 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 100 μL
Shipping to United States ( )
Availability Will be delivered in 7 to 8 Business Days
Immunogen A synthetic peptide from the internal region of human PIM1 conjugated to blue carrier protein was used as the antigen. The peptide is homologous in mouse.
Specificity Specific for PIM1.
Purification Whole serum
Alternative Name PIM1 (PIM1 Antibody Abstract)
Background Function: Is thought to be a target protein for the PIM1 kinase. May play some roles in B-cell proliferation in association with PIM1.Nucleus
Tissue specificity: Appears to be expressed in a wide range of tissues. DISEASE: Defects in RP9 are the cause of retinitis pigmentosa type 9 (RP9). RP leads to degeneration of retinal photoreceptor cells. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP9 inheritance is autosomal dominant. Also known as: Retinitis pigmentosa 9 protein, RP9, Pim-1-associated protein, PAP-1.
Research Area Cancer, Hematopoietic Progenitors
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user.
Not yet tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage 4 °C/-20 °C
Storage Comment Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date 12 months
Background publications Kuroda, Maita, Tabata et al.: "A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase." in: Gene, Vol. 340, Issue 1, pp. 83-98, 2004 (PubMed).

Keen, Hims, McKie et al.: "Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa." in: European journal of human genetics : EJHG, Vol. 10, Issue 4, pp. 245-9, 2002 (PubMed).

Catalog No. ABIN350744
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)